Birdwatch Note Rating
2024-11-29 04:37:20 UTC - NOT_HELPFUL
Rated by Participant: 0A5A303D272B5DF8FB49D20E689A0E42DCA858056D92EB1E3A931BE9B38E287E
Participant Details
Original Note:
The new rule proposal does not mandate Ozempic as an obesity treatment. The proposed rule changes a decades-old Medicare rule that prohibits the program from covering weight loss drugs. This makes Ozempic and other semaglutides available to those covered by Medicare. https://apnews.com/article/ozempic-biden-rfk-jr-trump-antiobesity-drugs-caaa2f888435af1d32bedb83e9ddbc0a
All Note Details